Farmaci

Lynparza▼ (Olaparib)

ATC
Farmaco orfano
No

Aggiornato 21 giorni fa

Tyverb (Lapatinib)

ATC
Farmaco orfano
No

Aggiornato 1 mese fa

Talzenna▼ (Talazoparib)

Farmaco orfano
No

Aggiornato 1 mese fa

Nerlynx▼ (Neratinib)

Farmaco orfano
No

Aggiornato 1 mese fa

Trazimera▼ (Trastuzumab)

ATC
Farmaco orfano
No

Aggiornato 9 mesi fa

Verzenios▼ (Abemaciclib)

Farmaco orfano
No

Aggiornato 9 mesi fa

Search all farmaci for Carcinoma mammario
 

Aree di apprendimento

Un'Area di apprendimento (AA) di epgonline.org è un'area del sito dedicata a fornire una formazione medica dettagliata e autogestita su una patologia, una malattia o una procedura.

CDK 4/6 inhibitors in metastatic breast cancer

CDK 4/6 inhibitors in metastatic breast cancer

The CDK 4/6 Inhibitors in Metastatic Breast Cancer Learning Zone provides insights and information for metastatic breast cancer (mBC) and CDK 4/6 signalling. This includes the burden and pathophysiology of the disease, the role of CDK 4/6 in cell proliferation and an overview of the CDK 4/6 inhibitors that have been approved for the management of mBC.

Centro didattico sui trapianti

Centro didattico sui trapianti

Vedi le informazioni sulle migliori pratiche del trapianto di organi e le discussioni tra esperti sui temi correlati.

Fibrinogen Deficiency in Bleeding

Fibrinogen Deficiency in Bleeding

Fibrinogen is important for blood clot formation and breakdown. It is the first coagulant factor to be reduced to critical levels during massive trauma, cardiac surgery and postpartum haemorrhage that involve excessive bleeding. Persistent fibrinogen deficiency can lead to bleeding complications and an increased risk in mortality. This learning zone looks at both congenital and acquired fibrinogen deficiencies including indications and techniques for diagnosis, trigger level for treatment and treatment options.

Carica altro